» Articles » PMID: 38936161

Disparities in Cancer Clinical Trials Information-seeking: Findings from the National Cancer Institute's Cancer Information Service

Overview
Publisher Elsevier
Specialties Health Services
Nursing
Date 2024 Jun 27
PMID 38936161
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To better understand cancer clinical trials (CCT) information-seeking, a necessary precursor to patient and provider engagement with CCT.

Methods: Data from the National Cancer Institute's Cancer Information Service (CIS) were used to examine CCT information-seeking patterns over a 5-year period. Descriptive and logistic regression analyses were conducted to examine characteristics of CIS inquiries and their associations with having a CCT discussion.

Results: Between September 2018 - August 2023, 117,016 CIS inquiries originated from cancer survivors, caregivers, health professionals, and the general public; 27.5 % of these inquiries included a CCT discussion (n = 32,160). Among CCT discussions, 35.5 % originated from survivors, 53.5 % from caregivers, 6.1 % from the public, and 4.9 % from health professionals. Inquiries in Spanish had lower odds of a CCT discussion (OR=.26, [.25-.28]), whereas inquiries emanating from the CIS instant messaging (OR=2.29, [2.22-2.37]) and email (OR=1.24, [1.18-1.30]) platforms were associated with higher odds of discussing CCT compared to the telephone. Individuals who were male, younger, insured, and had higher income and education had significantly higher odds of a CCT discussion while those who were non-Hispanic Black and living in rural locales had significantly lower odds.

Conclusions: Disparities in CCT information-seeking may contribute to downstream CCT participation.

Practice Implications: Quality, language-concordant health information is needed to enable equitable awareness of - and ultimately engagement in - CCT.

Citing Articles

Cancer prognosis information-seeking among survivors and caregivers: findings from the National Cancer Institute's Cancer Information Service.

Wilson A, Huang G, Kueppers G, Dwyer L, Han P, Vanderpool R Support Care Cancer. 2024; 33(1):30.

PMID: 39676139 PMC: 11646954. DOI: 10.1007/s00520-024-09089-8.

References
1.
Joffe S, Cook E, Cleary P, Clark J, Weeks J . Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001; 358(9295):1772-7. DOI: 10.1016/S0140-6736(01)06805-2. View

2.
Perocchia R, Hodorowski J, Williams L, Kornfeld J, Davis N, Monroe M . Patient-centered communication in cancer care: the role of the NCI's Cancer Information Service. J Cancer Educ. 2010; 26(1):36-43. DOI: 10.1007/s13187-010-0121-y. View

3.
Statler M, Wall B, Richardson J, Jones R, Kools S . African American Perceptions of Participating in Health Research Despite Historical Mistrust. ANS Adv Nurs Sci. 2022; 46(1):41-58. DOI: 10.1097/ANS.0000000000000435. View

4.
Crosson K, Slevin R, Keany J . Role of the Cancer Information Service in a national education initiative on cancer clinical trials. J Natl Cancer Inst Monogr. 1993; (14):131-7. View

5.
Langmuir T, Chu A, Sehabi G, Giguere L, Lamarche J, Boudjatat W . A new landscape in illness uncertainty: A systematic review and thematic synthesis of the experience of uncertainty in patients with advanced cancer receiving immunotherapy or targeted therapy. Psychooncology. 2023; 32(3):356-367. DOI: 10.1002/pon.6093. View